The arrival of drug treatment has made people living with Alzheimer’s more optimistic, says Dr. Nathaniel Chin, a geriatrician at the University of Wisconsin who was not involved in the survey.
“Even if it doesn’t stop the disease in its tracks, it tells people that we’re making progress,” he says. “They want to know if they potentially could have this therapy or maybe the next therapy or two therapies down the road.”